Dermatologicals in Belgium

Dermatologicals in Belgium

Dermatologicals in Belgium is projected to see a small rise in retail current value sales in 2024, despite decreases in retail volume terms in all categories except vaginal antifungals. Further, if slower, price rises underpin the anticipated positive, if slower, growth in retail current value sales at the end of the review period. Dermatologicals are not perceived as essential consumer health products and the purchase of these items is often postponed. However, as the taboo around sexuality and...

Euromonitor International's Dermatologicals in Belgium report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.

Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Dermatologicals, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Dermatologicals market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.